GAMCO Investors’s Apellis Pharmaceuticals APLS Stock Holding History

GAMCO Investors’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21,000	Closed	-$845K	–	945
2026 Q1	$845K	Buy	+21,000	New	+$453K	0.01%	655

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GAMCO Investors's APLS Position: Q2 2026 in Review

GAMCO Investors sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 21,000 shares — an estimated $845K sold.

GAMCO Investors first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $845K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

GAMCO Investors reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
GAMCO Investors sold 21,000 Apellis Pharmaceuticals shares in Q2 2026, an estimated $845K.
GAMCO Investors first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
GAMCO Investors's Apellis Pharmaceuticals position peaked at $845K in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on GAMCO Investors's 13F filing for Q2 2026, filed 12 Aug 2026.